EPIK-B3
Novartis
Novartis
Sotio Biotech Inc.
Genmab
Ocellaris Pharma, Inc.
Palleos Healthcare GmbH
Seagen Inc.
Fusion Pharmaceuticals Inc.
PharmAbcine
Regeneron Pharmaceuticals
Transgene
Bolt Biotherapeutics, Inc.
Novartis
Pfizer
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Nuvation Bio Inc.
Gilead Sciences
Zenith Epigenetics
NiKang Therapeutics, Inc.
CytoDyn, Inc.
MacroGenics
Ourotech, Inc.
Numab Therapeutics AG
Hutchmed
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Formation Biologics
Numab Therapeutics AG
Novartis
SK Life Science, Inc.
Kymab Limited
Chipscreen Biosciences, Ltd.
Seagen Inc.
G1 Therapeutics, Inc.
Novartis
Novartis
Pfizer
Hoffmann-La Roche
ImmunityBio, Inc.
Pfizer
ADC Therapeutics S.A.
Exelixis
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Ikena Oncology
Ayala Pharmaceuticals, Inc,
Gilead Sciences
pharmaand GmbH
Atreca, Inc.
Fate Therapeutics
Fate Therapeutics
NBE-Therapeutics AG